Type	HazMat fee for 500 gram (Estimated)
Excepted Quantity	USD 0.00
Limited Quantity	USD 15-60
Inaccessible (Haz class 6.1), Domestic	USD 80+
Inaccessible (Haz class 6.1), International	USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic	USD 100+
Accessible (Haz class 3, 4, 5 or 8), International	USD 200+

CAS No. :	97682-44-5
Formula :	C₃₃H₃₈N₄O₆
M.W :	586.68
SMILES Code :	O=C(N1CCC(N2CCCCC2)CC1)OC3=CC=C4N=C5C(CN6C(C(COC([C@@]7(CC)O)=O)=C7C=C65)=O)=C(CC)C4=C3
Synonyms :	CPT-11; VAL-413(free base); (+)-Irinotecan
MDL No. :	MFCD00866307

GHS Pictogram:
Signal Word:	Danger
Hazard Statements:	H301
Precautionary Statements:	P501-P270-P264-P301+P310+P330-P405
Class:	6.1
UN#:	1544
Packing Group:	Ⅲ

RKO cells	2.5 µM	96 hours	Induce cellular senescence and evaluate changes in cell proliferation, migration, and invasion abilities	Mol Cancer. 2024 Apr 4;23(1):70
HCT116 cells	1.5 µM	96 hours	Induce cellular senescence and evaluate changes in cell proliferation, migration, and invasion abilities	Mol Cancer. 2024 Apr 4;23(1):70
Pancreatic ductal adenocarcinoma PDX tumor tissue slices	10 μM, 30 μM	72 h	Test the sensitivity of PDX tumor tissue slices to irinotecan, results were consistent with patients' clinical responses.	Clin Cancer Res. 2016 Dec 15;22(24):6021-6030.
HT29 cells	3.125 to 100 µM	24 h	Irinotecan (CPT-11) as the positive control significantly inhibited the proliferation of HT29 cells, with a GI50 of 5.19 µM.	Biomolecules. 2019 Aug 27;9(9):418.
HT29-dx cells	1 µM	24 h	The anti-tumor effect of irinotecan on chemotherapy-resistant HT29-dx cells was studied. The results showed that irinotecan could reduce the IC50 value of drug-resistant cells and restore its anti-tumor effect	Mol Cancer. 2013 Nov 13;12:137.
HT-29 human colorectal cancer cells	20 µM	1.5 h	To investigate the effects of irinotecan alone or in combination with 5-FU on the growth, metabolic activity, and proliferation of HT-29 cells. The results showed that irinotecan alone or in combination with 5-FU significantly inhibited the growth, metabolic activity, and proliferation of HT-29 cells.	Int J Mol Sci. 2023 Jun 20;24(12):10385.
TFK-1 cells	20 µg/ml	72 h	Irinotecan treatment significantly reduced cell viability, increased cytotoxicity, and induced the expression of inflammation-related genes in TFK-1 cells.	Sci Rep. 2019 Mar 13;9(1):4338.
EGI-1 cells	20 µg/ml	72 h	Irinotecan treatment significantly reduced cell viability, increased cytotoxicity, and induced the expression of inflammation-related genes in EGI-1 cells.	Sci Rep. 2019 Mar 13;9(1):4338.

Nude mice	Pancreatic ductal adenocarcinoma PDX model	Not specified	50 mg/kg	Weekly for 3 weeks	Validate LTSA results, irinotecan significantly inhibited tumor growth.	Clin Cancer Res. 2016 Dec 15;22(24):6021-6030.
Mice	Orthotopic colon cancer model	Intravenous injection	40 mg/kg	Every third or fourth day	To evaluate the pharmacokinetics and tumor drug content of Ir-silicasome in a colon cancer model	ACS Nano. 2019 Jan 22;13(1):38-53
Mice	B16-Luc brain tumour model	Intravenous injection	50 μM/kg	Daily injection for 6 days	Irinotecan suppressed subcutaneous tumour growth but minimally suppressed brain tumour growth.	Br J Cancer. 2020 Nov;123(11):1633-1643
BALB/c nude mice	Subcutaneous xenograft model	Intraperitoneal injection	5 mg/kg	Twice a week for approximately 50 days	To study the role of eIF3a in irinotecan sensitivity in vivo, it was found that eIF3a downregulation increased resistance to irinotecan.	Cell Prolif. 2022 Apr;55(4):e13208
Mice	FLC PDX models	Intraperitoneal injection	5 mg/kg	Irinotecan: 5 days a week for 2 weeks; DT2216: Once or twice a week for 3 weeks	To evaluate the synergistic effect of Irinotecan and DT2216 in FLC PDX models, results showed that Irinotecan and DT2216 have remarkable synergy in vivo at clinically achievable doses not associated with significant thrombocytopenia	JCI Insight. 2022 Sep 8;7(17):e161820

{[proInfo.proName]}

CAS No.: 97682-44-5

{[proInfo.proName]}

CAS No.: 97682-44-5

Product Citations Show More

Alternative Products

Product Details of Irinotecan

Safety of Irinotecan

Related Pathways of Irinotecan

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

NCT00005626	Leukemia\|Lymphoma	PHASE2	COMPLETED	2025-11-03	H. Lee Moffitt Cancer Center a... More >>nd Research Institute, Tampa, Florida, 33612, United States Less <<
NCT02662959	Stomach Neoplasms	PHASE2	UNKNOWN	-	Shanghai Cancer Center, Shangh... More >>ai, Shanghai, China Less <<
NCT05391126	Colorectal Cancer\|Pancreatic C... More >>ancer Less <<		RECRUITING	2025-05-27	University of Kentucky, Lexing... More >>ton, Kentucky, 40506, United States Less <<
NCT00320320	Colorectal Neoplasms\|Metastase... More >>s Less <<	PHASE2	TERMINATED	2025-04-07	Gachon University Gil Medical ... More >>Center, Incheon, 405 760, Korea, Republic of Less <<
NCT00509860	Sarcoma	PHASE2	COMPLETED	2025-01-12	UT MD Anderson Cancer Center, ... More >>Houston, Texas, 77030, United States Less <<
NCT00072852	Breast Neoplasms	PHASE2	COMPLETED	2025-05-07	Pfizer Investigational Site, M... More >>obile, Alabama, 36608, United States\|Pfizer Investigational Site, Anchorage, Alaska, 99508, United States\|Pfizer Investigational Site, Lewistown, Idaho, 83501, United States\|Pfizer Investigational Site, Alton, Illinois, 62002, United States\|Pfizer Investigational Site, Indianapolis, Indiana, 46227, United States\|Pfizer Investigational Site, Overland Park, Kansas, 66210, United States\|Pfizer Investigational Site, Chalmette, Louisiana, 70043, United States\|Pfizer Investigational Site, Covington, Louisiana, 70433, United States\|Pfizer Investigational Site, Mandeville, Louisiana, 70448, United States\|Pfizer Investigational Site, Metairie, Louisiana, 70002, United States\|Pfizer Investigational Site, Metairie, Louisiana, 70006, United States\|Pfizer Investigational Site, New Orleans, Louisiana, 70115, United States\|Pfizer Investigational Site, Boston, Massachusetts, 02114, United States\|Pfizer Investigational Site, Boston, Massachusetts, 02115, United States\|Pfizer Investigational Site, Boston, Massachusetts, 02130, United States\|Pfizer Investigational Site, Detroit, Michigan, 48201, United States\|Pfizer Investigational Site, Southaven, Mississippi, 38671, United States\|Pfizer Investigational Site, Kansas City, Missouri, 64111, United States\|Pfizer Investigational Site, St. Louis, Missouri, 63136, United States\|Pfizer Investigational Site, St. Louis, Missouri, 63141, United States\|Pfizer Investigational Site, Washington, Missouri, 63090, United States\|Pfizer Investigational Site, New Brunswick, New Jersey, 08901-2601, United States\|Pfizer Investigational Site, New Brunswick, New Jersey, 08903, United States\|Pfizer Investigational Site, New York, New York, 10021, United States\|Pfizer Investigational Site, Stony Brook, New York, 11794, United States\|Pfizer Investigational Site, Kettering, Ohio, 45409, United States\|Pfizer Investigational Site, Oklahoma City, Oklahoma, 73120, United States\|Pfizer Investigational Site, Greenville, South Carolina, 29615, United States\|Pfizer Investigational Site, Covington, Tennessee, 38019, United States\|Pfizer Investigational Site, Franklin, Tennessee, 37067, United States\|Pfizer Investigational Site, Gallatin, Tennessee, 37066, United States\|Pfizer Investigational Site, Hermitage, Tennessee, 37076, United States\|Pfizer Investigational Site, Lebanon, Tennessee, 37087, United States\|Pfizer Investigational Site, Memphis, Tennessee, 38120, United States\|Pfizer Investigational Site, Murfreesboro, Tennessee, 37130, United States\|Pfizer Investigational Site, Nashville, Tennessee, 37203, United States\|Pfizer Investigational Site, Nashville, Tennessee, 37205, United States\|Pfizer Investigational Site, Nashville, Tennessee, 37207, United States\|Pfizer Investigational Site, Nashville, Tennessee, 37211, United States\|Pfizer Investigational Site, Dallas, Texas, 75204, United States\|Pfizer Investigational Site, Dallas, Texas, 75230-2510, United States\|Pfizer Investigational Site, Dallas, Texas, 75231, United States\|Pfizer Investigational Site, Dallas, Texas, 75246, United States\|Pfizer Investigational Site, Fort Worth, Texas, 76104, United States\|Pfizer Investigational Site, Plano, Texas, 75075-7787, United States\|Pfizer Investigational Site, Tyler, Texas, 75702, United States\|Pfizer Investigational Site, Federal Way, Washington, 98003, United States\|Pfizer Investigational Site, Lakewood, Washington, 98499, United States\|Pfizer Investigational Site, Seattle, Washington, 98104-2499, United States\|Pfizer Investigational Site, Seattle, Washington, 98104, United States\|Pfizer Investigational Site, Seattle, Washington, 98109-1023, United States\|Pfizer Investigational Site, Seattle, Washington, 98122, United States\|Pfizer Investigational Site, Seattle, Washington, 98195, United States\|Pfizer Investigational Site, Tacoma, Washington, 98405, United States\|Pfizer Investigational Site, Vancouver, Washington, 98684, United States\|Pfizer Investigational Site, Yakima, Washington, 98902, United States\|Pfizer Investigational Site, Milwaukee, Wisconsin, 53215, United States\|Pfizer Investigational Site, Capital Federal, Buenos Aires, 1426, Argentina\|Pfizer Investigational Site, Rosario, Santa Fe, 2000, Argentina\|Pfizer Investigational Site, Capital Federal, 1406, Argentina\|Pfizer Investigational Site, Cordoba, 5000, Argentina\|Pfizer Investigational Site, Santa Fe, 3000, Argentina\|Pfizer Investigational Site, South Brisbane, Queensland, 4101, Australia\|Pfizer Investigational Site, Frankston, Victoria, 3199, Australia\|Pfizer Investigational Site, Bogota, Bogota DC, 464, Colombia\|Pfizer Investigational Site, Wellington, 489, New Zealand Less <<
NCT01654081	Lung Cancer	PHASE2	WITHDRAWN	2025-05-14	-
NCT00144378	Stomach Neoplasm\|Neoplasm Meta... More >>stasis Less <<	PHASE3	COMPLETED	-	Charité,Universit?tsmedizin Be... More >>rlin, Campus Virchow Klinikum, Dep. orf Hematology and Oncology,, Berlin, Germany Less <<
NCT01826396	Colonic Neoplasms	PHASE2	UNKNOWN	2025-12-14	Colorectal Cancer Institute of... More >> the Heilongjiang Academy of Medical Sciences, Harbin, Heilongjiang, 150001, China Less <<
NCT01635400	Small Cell Carcinoma of Lung	PHASE2	UNKNOWN	2025-06-14	Zhejiang Cancer Hospital, Hang... More >>zhou, Zhejiang, China Less <<
NCT01607554	Non-small Cell Lung Cancer	PHASE1\|PHASE2	TERMINATED	2025-03-13	Hematology Oncology Associates... More >>, Albuquerque, New Mexico, 87106, United States\|University of New Mexico Cancer Center, Albuquerque, New Mexico, 87131, United States\|New Mexico Cancer Care Associates, Santa Fe, New Mexico, 87505, United States Less <<
NCT00222443	Lymphomas\|Tumors	PHASE1	COMPLETED	2025-12-07	Oklahoma University Health Sci... More >>ences Center-Jimmy Everest Center, Oklahoma City, Oklahoma, 73104, United States Less <<
NCT00062842	Cancer	PHASE1	COMPLETED	2006-09-12	Texas Children's Hospital, Hou... More >>ston, Texas, 77030, United States Less <<
NCT01239485	Acute Leukemia	PHASE1	UNKNOWN	2025-12-13	Seoul National University Hosp... More >>ital, Seoul, Chongno-gu, 110-744, Korea, Republic of Less <<
NCT01963182	First Line Metastatic Colorect... More >>al Cancer Less <<	PHASE2	COMPLETED	2019-12-09	Clinique de la Chataigneraie, ... More >>Beaumont, 63110, France\|Centre Jean Perrin, Clermont-Ferrand, 63011, France\|CHU Estaing, Clermont-Ferrand, 63011, France Less <<
NCT00037804	Unspecified Adult Solid Tumor\|... More >>Chemotherapy\|Liver Dysfunction\|Neoplasms, Solid Tumor Less <<	PHASE1	COMPLETED	-	Research Center, Detroit, Mich... More >>igan, 48201, United States\|Research Center, New Brunswick, New Jersey, 08901, United States\|Research Center, Nashville, Tennessee, 37232, United States\|Research Center, Marshfield, Wisconsin, 54449, United States Less <<
NCT03329183	Colorectal Cancer	PHASE2	UNKNOWN	2025-03-22	Shanghai Changzheng Hospital, ... More >>Shanghai, Shanghai, 200433, China Less <<
NCT03562390	Breast Cancer	PHASE2	UNKNOWN	2025-12-21	Cancer Hospital of China Medic... More >>al University, Shenyang, Liaoning, China Less <<
NCT00136955	Uterine Cervical Neoplasms	PHASE2	COMPLETED	2025-05-08	Pfizer Investigational Site, K... More >>aoshiung, 813, Taiwan\|Pfizer Investigational Site, Kwei-Shan County, TaoYuan,, Taiwan\|Pfizer Investigational Site, Taichung, Taiwan\|Pfizer Investigational Site, Taipei, 112, Taiwan\|Pfizer Investigational Site, Taipei, Taiwan Less <<
NCT00708773	Advanced Cancer	PHASE1	COMPLETED	2025-08-16	University of Chicago, Chicago... More >>, Illinois, 60637, United States\|NorthShore University HealthSystem, Evanston, Illinois, 60201, United States Less <<

Bio Calculators
Preparing Stock Solutions		1mg	5mg	10mg
Preparing Stock Solutions	1 mM 5 mM 10 mM	1.70mL 0.34mL 0.17mL	8.52mL 1.70mL 0.85mL	17.05mL 3.41mL 1.70mL
Dissolving Methods	Animal experiment Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn: in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Protocol 1 Protocol 2

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed